TITLE

Coronary artery flow reserve in diabetics with erectile dysfunction using sildenafil

AUTHOR(S)
Dietz, Ulrich; Tries, Hans-Peter; Merkle, Walter; Jaursch-Hancke, Cornelia; Lambertz, Heinz
PUB. DATE
January 2003
SOURCE
Cardiovascular Diabetology;2003, Vol. 2, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Background: Diabetics with erectile dysfunction have a high prevalence of microvascular disturbance of the coronary circuit as measured by coronary flow reserve (CFR). Purpose: We aimed to evaluate the effects of the phosphodiesterase 5 inhibitor sildenafil on CFR in diabetics with erectile dysfunction. Methods: Diabetics seeking diabetes refinement therapy were screened for vascular or neurogenic erectile dysfunction which was confirmed in 43 patients. No ischemic ECG changes were found in any of the ECG stress tests at the 100 W level. Cardiologic examinations raised suspicion of coronary artery disease in 16 patients; coronary angiography confirmed severe coronary artery lesions in 12, who were excluded from further analysis. CFR measurements were not possible in 10 participants. The 21 diabetics eligible for CFR measurements aged 60 years (50-69) had known diabetes for 11 years (3-30) and a BMI of 27 kg/m² (24-36). CFR of the left anterior descending artery was assessed at baseline and 1 hour after 50 mg sildenafil, using transthoracic Doppler echocardiography. Results: Baseline CFR was at the lower level of the normal range (median 245%, range 210 - 490%). After sildenafil administration, CFR decreased insignificantly (ΔCFR -10%, p = 0.3). Patients with a BMI > 25 kg/m²2 and left ventricular hypertrophy exhibited the highest reduction of CFR after sildenafil. No decrease of CFR below 200 % was observed. Systemic blood pressure dropped from 130/80 mmHg to 120/72 mmHg (p < 0.002). Conclusions: Diabetics with erectile dysfunction exhibit a CFR in the lower normal range indicating severe microvascular disturbance. Sildenafil did not alter CFR in those patients. A high prevalence of severe coronary macroangiopathy was identified in asymptomatic diabetic patients screened for contraindications for sildenafil.
ACCESSION #
28683673

 

Related Articles

  • Coronary Microvascular Dysfunction Linked to Endothelial Caveolae Disruption and NOS Uncoupling. Chou, Wendy // Diabetes;Apr2014, Vol. 63 Issue 4, p1167 

    The article presents an introduction to a report regarding the relationship between decreased flow-mediated dilation (FMD) in the coronary arterioles of patients with diabetes and the lipid raft endothelial caveolae.

  • Optimization of flow reserve measurement using SPECT technology to evaluate the determinants of coronary microvascular dysfunction in diabetes. Marini, Cecilia; Bezante, GianPaolo; Gandolfo, Patrizia; Modonesi, Elisa; Morbelli, Silvia D.; DePascale, Angelo; Rollando, Daniela; Maggi, Davide; Albertelli, Manuela; Armonino, Riccardo; Balbi, Manrico; Brunelli, Claudio; Cordera, Renzo; Sambuceti, Gianmario // European Journal of Nuclear Medicine & Molecular Imaging;Feb2010, Vol. 37 Issue 2, p357 

    The aim of this study was to validate a new method to measure regional myocardial perfusion reserve (MPR) with technetium-labelled tracers in patients with type 2 diabetes mellitus (DM2). A total of 40 consecutive DM2 patients without history of coronary artery disease (CAD) and 7 control...

  • Redefining the Role of Long-Acting Phosphodiesterase Inhibitor Tadalafil in the Treatment of Diabetic Erectile Dysfunction. Bruzziches, Roberto; Greco, Emanuela A.; Pili, Marcello; Francomano, Davide; Spera, Giovanni; Aversa, Antonio // Current Diabetes Reviews;2008, Vol. 4 Issue 1, p24 

    Diabetes mellitus (DM) is an established risk factor predisposing to male erectile dysfunction (ED), and it has been calculated that more than 50% of diabetic men develop ED within ten years of diagnosis. It has been suggested that the risk of ED increases with metabolic indices of inadequate...

  • CORONARY GRAFT FLOW AND GLUCOSE TOLERANCE: EVIDENCE AGAINST THE EXISTENCE OF MYOCARDIAL MICROVASCULAR DISEASE. Barner, Hendrick B.; Kaiser, George C.; Codd, John E.; Willman, Vallee L. // Vascular Surgery;Sep/Oct1975, Vol. 9 Issue 4, p220 

    Patients having coronary bypass for stable angina pectoris were grouped on the basis of the two hour plasma sugar of the glucose tolerance test: Group I. 120 mgs% (159 grafts): Group II. 120-150 (93 grafts); Group III. 150-200 (131 grafts) and Group IV. 200 (57 grafts) or patients receiving...

  • Structural alterations of the coronary arterial wall are associated with myocardial flow heterogeneity in type 2 diabetes mellitus. Schindler, Thomas; Facta, Alvaro; Prior, John; Cadenas, Jerson; Zhang, Xiao-Li; Li, Yanjie; Sayre, James; Goldin, Jonathan; Schelbert, Heinrich // European Journal of Nuclear Medicine & Molecular Imaging;Feb2009, Vol. 36 Issue 2, p219 

    To determine the relationship between carotid intima–media thickness (IMT), coronary artery calcification (CAC), and myocardial blood flow (MBF) at rest and during vasomotor stress in type 2 diabetes mellitus (DM). In 68 individuals, carotid IMT was measured using high-resolution vascular...

  • Erectile dysfunction as a cardiovascular risk factor in patients with diabetes. Gandaglia, Giorgio; Salonia, Andrea; Passoni, Niccolò; Montorsi, Piero; Briganti, Alberto; Montorsi, Francesco // Endocrine (1355008X);Apr2013, Vol. 43 Issue 2, p285 

    Erectile dysfunction (ED) is a highly prevalent disorder among patients with diabetes mellitus (DM). In most cases, ED is considered a vascular disease and its development is significantly related to the exposure to CVD risk factors. In this context, ED and coronary artery disease (CAD) have...

  • The issue hiding under the sheets. Cameron, Therese // Australian Nursing Journal;Sep2008, Vol. 16 Issue 3, p39 

    The article focuses on the link between diabetes and erectile dysfunction. Elevated blood glucose levels can cause impotence. Elevated blood glucose levels over a period of time can cause damage to nerves surrounding the penis and reduction in blood flow caused by narrowing and hardening of...

  • Key Global Literature. Fonseca, Vivian // Diabetes Care;Apr2002, Vol. 25 Issue 4, p805 

    Features abstracts of several studies on diabetes. 'Erectile and Endothelial Dysfunction in Type II Diabetes: A Possible Link,' by L. de Angelis et al; 'Sildenafil Citrate for the Treatment of Erectile Dysfunction in Men with Type II Diabetes Mellitus,' by A.J. Boulton et al; 'C-reactive...

  • MICRODETERMINATION OF SILDENAFIL, TADALAFIL AND VARDENAFIL DRUGS EMPLOYED IN THE ERECTILE DYSFUNCTION THERAPY IN PHARMACEUTICAL FORMULATIONS AND URINE SAMPLES OF DIABETIC PATIENTS TYPE-II IN TAIF AREA, SAUDIA ARABIA USING ATOMIC EMISSION AND ATOMIC... SABRY KH. MOHAMED; NAGLAA M. SHALABY // International Journal of Pharma & Bio Sciences;Jan-Mar2013, Vol. 4 Issue 1, pP-1037 

    Ion - associate complexes of sildenafil, tadalafil and vardenafil hydrochlorides with [ Manganese(ll) and Cobalt(ll)] thiocyanates, potassium ferricyanide, sodium cobaltinitrite and ammonium reineckate were precipitated and the excess unreacted metal complex was determined. A new method using...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics